Nicholas-

Innovatum, Inc. has a product called DataThreadTM that is designed to work
with any AS400 application including BPCS.  It was designed specifically for
21CFR Part11 compliance, the U.S. Food & Drug Administration ruling on
electronic records and signatures.  As such it is able to audit changes to
the field level and store the before/after image in a secured file.  It is
capable of much more including the ability to capture electronic signature,
establish workflow sequencing, provide automated real-time electronic
notifications, and more.  Please check this product at
http://www.innovatum.com/datathread.htm.

Feel free to contact us through our website or by phone at 770-945-4595.

Thank you

Dana Buker
Vice President, Operations
Innovatum.com
danab@innovatum.com
770-945-4595

-----Original Message-----
From: bpcs-l-admin@midrange.com [mailto:bpcs-l-admin@midrange.com]On
Behalf Of Carter, Nicholas (ZA - Durban)
Sent: Friday, July 05, 2002 2:57 AM
To: 'bpcs-l@midrange.com'
Subject: BPCS Audit Programs


Dear Members,

If any of you have come across audit programs for standard BPCS modules, or
have developed some with the help of your own internal audit departments and
do not mind sharing them, I would really appreciate you sending me or
posting on the site anything you might have.

Kindest regards,

Nicholas Carter
South Africa
_______________________________________________
This is the SSA's BPCS ERP System (BPCS-L) mailing list
To post a message email: BPCS-L@midrange.com
To subscribe, unsubscribe, or change list options,
visit: http://lists.midrange.com/cgi-bin/listinfo/bpcs-l
or email: BPCS-L-request@midrange.com
Before posting, please take a moment to review the archives
at http://archive.midrange.com/bpcs-l.




This thread ...

Replies:

Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2020 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].